Back to results
US 2014/0005122 A1Published application
Gemcitabine combination therapy
AssigneeCelgene Corporation
InventorsWilliam MCCULLOCH, Mitchell KEEGAN
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for the treatment of cell proliferative disorders using at least one DAC inhibitor and gemcitabine.
Claims9
A method comprising steps of:
- administering to a subject suffering from or susceptible to a cell proliferative disorder,
- combination therapy of a DAC inhibitor and gemcitabine.
Dependencies are inferred from the claim text.